84
Views
1
CrossRef citations to date
0
Altmetric
Open Peer Commentaries

The History of Enhancement? Or of Pharmacology?

Pages 33-34 | Published online: 18 Apr 2012

REFERENCES

  • Bell , S. K. , Lucke , J. C. and Hall , W. D. 2012 . Lessons for enhancement from the history of cocaine and amphetamine use . AJOB Neuroscience , 3 ( 2 ) : 24 – 29 .
  • Berardi , R. R. 2001 . Proton pump inhibition. An effective, safe approach to GERD management . Postgraduate Medicine , : 24 – 35 . special issue (October)
  • Corley , D. A. , Kubo , A. , Zhao , W. and Quesenberry , C. 2010 . Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients . Gastroenterology , 139 ( 1 ) : 93 – 101 . doi: 10.1053/j.gastro.2010.03.055
  • Katz , M. H. 2010 . Failing the acid test: Benefits of proton pump inhibitors may not justify the risks for many users . Archives of Internal Medicine , 170 ( 9 ) : 747 doi:10.1001/archinternmed.2010.64
  • Lynch , G. , Palmer , L. C. and Gall , C. M. 2011 . The likelihood of cognitive enhancement . Pharmacology, Biochemistry, and Behavior , 99 ( 2 ) : 116 – 129 . doi: 10.1016/j.pbb.2010.12.024
  • Neafsey , P. 2004 . Proton pump inhibitors go over the counter . Home Healthcare Nurse , 22 ( 4 ) : 214 – 215 .
  • Schepp , W. 1996 . Proton pump inhibitory therapy: Then and now . Yale Journal of Biology and Medicine , 69 ( 2 ) : 175 – 186 .
  • Schröder-Bernhardi , D. , Roth , K. and Dietlein , G. 2004 . Off-label use of proton pump inhibitors and P-blockers in general practices: an analysis using the Disease Analyzer—Mediplus patient database.” . International Journal of Clinical Pharmacology and Therapeutics , 42 ( 11 ) : 581 – 588 .
  • Thomson , A. B. R. , Sauve , M. D. , Kassam , N. and Kamitakahara , H. 2010 . Safety of the long-term use of proton pump inhibitors . World Journal of Gastroenterology , 16 ( 19 ) : 2323 – 2330 .
  • Walan , A. 1989 . The clinical utility and safety of omeprazole . Scandinavian Journal of Gastroenterology Supplement , 166 : 140 – 144 . discussion 145

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.